When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMRA - Is Biomerica Stock A Buy Or Sell After Q4 Earnings? Catalysts To Watch Into 2022
Biomerica Inc.
Biomerica recently reported its fiscal 2021 Q4 results highlighted by key product updates supporting a positive long-term outlook.
The company's irritable bowel syndrome "IBS" diagnostic therapy technology platform continues to move towards an FDA approval representing a significant growth opportunity.
While the stock has been volatile, we believe upcoming catalysts can drive shares higher through 2022.